Table 3: (Mean ± SD) for age, duration, VEGF-A and sorbitol by study groups.
|
Mean ± SD |
p (ANOVA) |
LSD (Groups) |
p (LSD) |
| Age (years) |
| A) DNR |
(38.9 ± 17.9) |
|
A X B |
<0.001 |
| B) NPDR |
(55.5 ± 10.0) |
<0.001 |
A X C |
<0.001 |
| C) PDR |
(54.3 ± 11.4) |
|
B X C |
0.604(NS) |
| Duration (years) |
| A) DNR |
(5.9 ± 3.8) |
<0.001 |
A X B |
< 0.001 |
| B) NPDR |
(13.6 ± 5.7) |
|
A X C |
< 0.001 |
| C) PDR |
(15.2 ± 6.9) |
|
B X C |
0.120(NS) |
| HbA1c (%) |
| A) DNR |
(9.03 ± 1.9) |
0.429 |
A X B |
0.570 |
| B) NPDR |
(9.27 ± 2.1) |
|
A X C |
0.213 |
| C) PDR |
(9.6 ± 2.4) |
|
B X C |
0.347 |
| VEGF-A (ng/ml) |
| A) DNR |
(96.0 ± 59.9) |
< 0.001 |
A X B |
<0.001 |
| B) NPDR |
(269.1 ± 218.3) |
|
A X C |
<0.001 |
| C) PDR |
(413.7 ± 301.4) |
|
B X C |
0.001 |
| Sorbitol (mg/L) |
| A) DNR |
(0.290 ± 0.031) |
<0.001 |
A X B |
<0.001 |
| B) NPDR |
(0.356 ± 0.065) |
|
A X C |
<0.001 |
| C) PDR |
(0.442 ± 0.133) |
|
B X C |
<0.001 |